Skip to main content

ADARx Pharmaceuticals to Present at the UBS Global Biopharma Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

SAN DIEGO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (Nasdaq: ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, today announced that Zhen Li, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the UBS Global Biopharma Conference in London, UK on Monday, November 16, at 2:00 p.m. GMT.

A live webcast will be available on the Events page of ADARx’s investor website. A replay of the conference webcast will be archived on the company's website for 90 days.

About ADARx Pharmaceuticals
ADARx Pharmaceuticals, Inc. is a late-clinical stage biotechnology company focused on developing next-generation RNA therapeutics designed to treat a broad spectrum of diseases. We are focused on advancing and expanding our pipeline of highly potent, selective and durable siRNA therapeutic candidates, including three clinical-stage programs and two advanced preclinical programs. Our three hepatic-targeted programs are agazisiran, onvuzosiran and ADX-626, and our two extrahepatic-targeted programs are ADX-077 and ADX-199. Beyond our named programs, we plan to continue to leverage our proprietary technologies to strategically expand our pipeline of next-generation siRNA therapeutics. Our goal is to control the expression of specific disease drivers with highly selective RNA targeted therapies, delivering life-changing treatments for patients with urgent unmet medical needs.


Contacts

Investors: ir@adarx.com

Media: teri@redhousecomms.com
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  255.47
-1.90 (-0.74%)
AAPL  350.43
+1.22 (0.35%)
AMD  463.35
-25.84 (-5.28%)
BAC  48.41
-0.16 (-0.32%)
GOOG  277.39
+6.37 (2.35%)
META  580.25
-15.97 (-2.68%)
MSFT  498.32
+0.02 (0.01%)
NVDA  139.84
-6.14 (-4.21%)
ORCL  107.22
-3.34 (-3.03%)
TSLA  368.83
-5.58 (-1.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.